These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27484509)
1. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors. Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252 [TBL] [Abstract][Full Text] [Related]
3. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of celastrol derivatives as potential non-nucleoside hepatitis B virus inhibitors. Zhang H; Lu G Chem Biol Drug Des; 2020 Dec; 96(6):1380-1386. PubMed ID: 32573976 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents. Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents. Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors. Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984 [TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis B virus activities of friedelolactones from Viola diffusa Ging. Dai JJ; Tao HM; Min QX; Zhu QH Phytomedicine; 2015 Jul; 22(7-8):724-9. PubMed ID: 26141758 [TBL] [Abstract][Full Text] [Related]
11. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication. Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826 [TBL] [Abstract][Full Text] [Related]
12. [Design, virtual screening, synthesis and anti-hepatitis B virus of oxime derivatives]. Cui XH; Tan J; Zhou M; Wei WX; Liu X; Wang LS Yao Xue Xue Bao; 2016 Oct; 51(10):1578-83. PubMed ID: 29932603 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. Liu S; Li Y; Wei W; Wang K; Wang L; Wang J Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors. Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors. Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new 2'-deoxy-2'-fluoro-4'-triazole cytidine nucleosides as potent antiviral agents. Wu J; Yu W; Fu L; He W; Wang Y; Chai B; Song C; Chang J Eur J Med Chem; 2013 May; 63():739-45. PubMed ID: 23570720 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region. Yu J; Jia H; Guo X; Desta S; Zhang S; Zhang J; Ding X; Liang X; Liu X; Zhan P Chem Biol Drug Des; 2020 Jun; 95(6):567-583. PubMed ID: 30825248 [TBL] [Abstract][Full Text] [Related]
18. Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation. Tan J; Zhou M; Cui X; Wei Z; Wei W Molecules; 2018 Mar; 23(3):. PubMed ID: 29534537 [TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis B virus active constituents from Swertia chirayita. Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-HBV activities evaluation of new ethyl 8-imidazolylmethyl-7-hydroxyquinoline-3-carboxylate derivatives in vitro. Liu Y; Zhao Y; Zhai X; Liu X; Sun L; Ren Y; Gong P Arch Pharm (Weinheim); 2008 Jul; 341(7):446-52. PubMed ID: 18574853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]